BioCentury | Oct 13, 1997
Finance

Pipeline fill

...patterns of gene expression and regulation. A group of investors - including Oxford Bioscience Partners, Hambro Health International...
...patterns of gene expression and regulation. A group of investors - including Oxford Bioscience Partners, Hambro Health International...
BioCentury | Jul 21, 1997
Emerging Company Profile

Gene Logic Inc.

...College of Medicine Number of employees: 45 Funds raised: $30 million Investors: Oxford Bioscience Partners; Hambro Health International...
BioCentury | Apr 7, 1997
Company News

SunPharm board of directors update

...SunPharm Corp. (SUNP), Jacksonville, Fla. Business: Cancer, Infectious diseases/AIDS Appointed: Charles Dimmler III, president of Hambro Health International...
Items per page:
1 - 3 of 3
BioCentury | Oct 13, 1997
Finance

Pipeline fill

...patterns of gene expression and regulation. A group of investors - including Oxford Bioscience Partners, Hambro Health International...
...patterns of gene expression and regulation. A group of investors - including Oxford Bioscience Partners, Hambro Health International...
BioCentury | Jul 21, 1997
Emerging Company Profile

Gene Logic Inc.

...College of Medicine Number of employees: 45 Funds raised: $30 million Investors: Oxford Bioscience Partners; Hambro Health International...
BioCentury | Apr 7, 1997
Company News

SunPharm board of directors update

...SunPharm Corp. (SUNP), Jacksonville, Fla. Business: Cancer, Infectious diseases/AIDS Appointed: Charles Dimmler III, president of Hambro Health International...
Items per page:
1 - 3 of 3